Road mapping ATLAS ACS 2: are we there yet?
Paul W
PW
Armstrong
Robert A
RA
Harrington
D054058:Acute Coronary Syndrome / Q000150:complications*; D001281:Atrial Fibrillation / Q000188:drug therapy; D003328:Coronary Thrombosis / Q000517:prevention & control*; D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D012008:Recurrence; D020521:Stroke / Q000517:prevention & control
D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors